DLA Piper advises on Sperco Ukraine investment
DLA Piper Ukraine has advised Europe Virgin Fund (EVF), a private equity fund, sponsored by Dragon Capital in set up of a joint venture with Ucrafarma SA.
The parties invested into Lux PHARMA Participations SA, a Luxembourg-based holding company, with Ucrafarma SA transferring various pharmaceutical assets including its 95 per cent stake in Sperco Ukraine LLC, one of the top 10 pharmaceutical manufacturers of Ukraine, and EVF providing capital for further development
DLA Piper provided full legal support to the transaction, including legal due diligence of Ukrainian and Spanish assets, drafting and negotiating transactional documents governed by English, Ukrainian and Spanish law, support of closing of the deal.
The DLA Piper team was led by legal director Illya Muchnyk under the general supervision of managing partner Margarita Karpenko. The significant input was provided by finance and projects associates Dmytro Pshenychnyuk, Maxim Andrianov, Dmytro Lapa and real estate associates — Oleg Matiusha.
News from DLA Piper
News from The Lawyer
Briefings from DLA Piper
Global Financial Markets Insight — the case for a better-functioning securitisation market; the cost of holding ABS; and more
DLA Piper has released the latest version (issue 4, Q3 2014) of its Global Financial Markets Insight publication.
Corporate Insurance Trends 2014 is a collection of articles highlighting some trends and key issues for financial lines insurers and their insureds in 2014.
Analysis from The Lawyer
Shearman & Sterling is making its presence felt in the City, squaring up to magic circle firms and looking to muscle in on key relationships. Private equity house Bridgepoint is one outfit that has had its head turned by the US firm.
A new breed of lawyer is smoothing the path for companies entering emerging or unstable jurisdictions